Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (171-180 of 418) with videos related to

Pageof 42
Sort By:
Bulletin Du Cancer|October 8, 2013
[Comparative cost analysis of molecular biology methods in the diagnosis of sarcomas]Sandrine Baffert, Antoine Italiano, Gaëlle Pierron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomasAntoine Italiano, Laurence Bianchini, Elisabet Gjernes, et al.
European Journal of Cancer (Oxford, England : 1990)|November 12, 2025
Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patientsAlexia Mirandola, Jérôme Cartry, Sabrina Bedja, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Benjamin Besse, et al.
NPJ Precision Oncology|June 7, 2024
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosisAmandine Crombé, Carlo Lucchesi, Frédéric Bertolo, et al.
Plos One|April 17, 2015
Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancersPaolo Puccetti, Francesca Fallarino, Antoine Italiano, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumorsAntoine Adenis, Olivier Bouché, François Bertucci, et al.
Journal of Hematology & Oncology|October 28, 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket studyMariella Spalato-Ceruso, Fanny Bouteiller, Jean-Philippe Guegan, et al.
Frontiers in Immunology|March 21, 2020
IDO Targeting in Sarcoma: Biological and Clinical ImplicationsImane Nafia, Maud Toulmonde, Doriane Bortolotto, et al.
Pageof 42

Showing results (171-180 of 418) with videos related to

Sort By:
Pageof 42
Bulletin Du Cancer|October 8, 2013
[Comparative cost analysis of molecular biology methods in the diagnosis of sarcomas]Sandrine Baffert, Antoine Italiano, Gaëlle Pierron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomasAntoine Italiano, Laurence Bianchini, Elisabet Gjernes, et al.
European Journal of Cancer (Oxford, England : 1990)|November 12, 2025
Characterization of the cell-free DNA released by tumor organoids derived from colorectal cancer patientsAlexia Mirandola, Jérôme Cartry, Sabrina Bedja, et al.
Journal for Immunotherapy of Cancer|January 12, 2022
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signatureFrancois Bertucci, Vincent Niziers, Alexandre de Nonneville, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Benjamin Besse, et al.
NPJ Precision Oncology|June 7, 2024
Integration of pre-treatment computational radiomics, deep radiomics, and transcriptomics enhances soft-tissue sarcoma patient prognosisAmandine Crombé, Carlo Lucchesi, Frédéric Bertolo, et al.
Plos One|April 17, 2015
Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancersPaolo Puccetti, Francesca Fallarino, Antoine Italiano, et al.
Medical Oncology (Northwood, London, England)|March 27, 2012
Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumorsAntoine Adenis, Olivier Bouché, François Bertucci, et al.
Journal of Hematology & Oncology|October 28, 2022
Pembrolizumab combined with low-dose cyclophosphamide and intra-tumoral injection of the toll-like receptor 4 agonist G100 in patients with advanced pretreated soft tissue sarcoma: results from the PEMBROSARC basket studyMariella Spalato-Ceruso, Fanny Bouteiller, Jean-Philippe Guegan, et al.
Frontiers in Immunology|March 21, 2020
IDO Targeting in Sarcoma: Biological and Clinical ImplicationsImane Nafia, Maud Toulmonde, Doriane Bortolotto, et al.
Pageof 42